Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-Market

DelMar Pharmaceuticals, Inc. Name Change to Kintara Therapeutics, Inc. Kintara Therapeutics to Trade on Nasdaq Capital Market under the Ticker Symbol "KTRA" SAN DIEGO, Aug. 20, 2020 -- (Healthcare Sales & Marketing Network) -- Kintara Ther... Biopharmaceuticals, Oncology, Mergers & Acquisitions Kintara Therapeutics, DelMar Pharmaceuticals, Adgero Biopharmaceuticals
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news